Emotion Regulation Intervention to Sustain Physical Activity in Rural-dwelling Women and Men After Myocardial Infarction
eMotion
1 other identifier
interventional
40
1 country
4
Brief Summary
The purpose of this study is to evaluate early preliminary efficacy of the eMotion intervention in US adults who have experienced a first cardiac event and participating in phase II cardiac rehabilitation. This study will evaluate early efficacy and evaluate the cognitive processes as intervention response variables. Investigators will also examine the relationships between emotion regulation and other cognitive processes and symptoms (threat and stress, cognition and motivation), symptoms \[depression, anxiety, pain, sleep, and fatigue\]), and health related quality of life among adults enrolled in cardiac rehabilitation after a first cardiac event.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2020
CompletedFirst Posted
Study publicly available on registry
June 22, 2020
CompletedStudy Start
First participant enrolled
January 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2023
CompletedOctober 24, 2023
October 1, 2023
2.3 years
June 11, 2020
October 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Moderate to Vigorous Physical Activity (MVPA)
Minutes spent in MVPA
1 week trials at baseline, 12 weeks, 20 weeks, and 52 weeks
Secondary Outcomes (5)
Change in Depression Symptoms
Baseline to 12 weeks, 20 weeks, and 52 weeks
Change in Anxiety Symptoms
Baseline to 12 weeks, 20 weeks, and 52 weeks
Change in Pain Symptoms
Baseline to 12 weeks, 20 weeks, and 52 weeks
Change in Sleep efficiency
Baseline to 12 weeks, 20 weeks, and 52 weeks
Change in Fatigue Symptoms
Baseline to 12 weeks, 20 weeks, and 52 weeks
Study Arms (3)
eMotion
EXPERIMENTALThe eMotion intervention is based on feasibility testing of the successful in-person program with critical refinement to improve accessibility. eMotion has undergone subsequent content validity testing with intervention development, self-management, cardiovascular health, and health information technology delivery experts. eMotion teaches a carefully selected repertoire of emotion regulation strategies well suited for aging rural adults following a first cardiac event in tandem with usual cardiac rehabilitation. The intervention helps patients recognize their emotions, balance emotional and physical wellbeing, and implement emotion regulation strategies effectively. Intervention provided in addition to usual cardiac rehabilitation.
Healthy living active control
ACTIVE COMPARATORHealthy living strategies based on American Heart Association education. Intervention provided in addition to usual cardiac rehabilitation.
Usual care
NO INTERVENTIONUsual cardiac rehabilitation with no additional intervention.
Interventions
Content is delivered within the context of emotion provoking situations common in those recovering from a first MI and in maintaining MVPA. The new on-demand access to asynchronous content sessions provides didactic presentation of video and written material based on weekly needs assessments. Weekly scheduled synchronous video chat sessions, led by a nurse interventionist, will provide further individualization and application of content materials.
The attention control group will receive their usual cardiac rehabilitation and a comparable dose matched (to that of the eMotion intervention) of healthy living web content and video chat with a nurse.
Eligibility Criteria
You may qualify if:
- First time major cardiac event as documented in medical record;
- enrolled in cardiac rehabilitation phase II program;
- living independently; and
- at least mild symptoms of depression and/or anxiety (determined by standardized measure cutpoints).
You may not qualify if:
- does not speak English;
- major Axis 1 psychiatric diagnosis (e.g. schizophrenia);
- terminal cancer; and
- legally blind
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- Sigma Theta Tau International Honor Society of Nursingcollaborator
- Jonas Philanthropiescollaborator
Study Sites (4)
Indiana University Health West Hospital
Avon, Indiana, 46123, United States
Indiana University Health Bedford Hospital
Bedford, Indiana, 47421, United States
Indiana University Health Methodist Hospital
Indianapolis, Indiana, 46202, United States
Indiana University Health Tipton Hospital
Tipton, Indiana, 46072, United States
Related Publications (1)
Dibben G, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler AD, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
PMID: 34741536DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kelly L Wierenga, PhD
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Nursing
Study Record Dates
First Submitted
June 11, 2020
First Posted
June 22, 2020
Study Start
January 12, 2021
Primary Completion
May 1, 2023
Study Completion
October 10, 2023
Last Updated
October 24, 2023
Record last verified: 2023-10